vs
Assertio Holdings, Inc.（ASRT）与La Rosa Holdings Corp.（LRHC）财务数据对比。点击上方公司名可切换其他公司
La Rosa Holdings Corp.的季度营收约是Assertio Holdings, Inc.的1.5倍（$20.2M vs $13.5M），La Rosa Holdings Corp.同比增速更快（3.2% vs -57.9%），过去两年La Rosa Holdings Corp.的营收复合增速更高（72.5% vs -35.4%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
拉罗萨控股旗下的万拉罗萨父子通心粉公司由西西里移民文森佐·拉罗萨于1914年创立，发展至今已成为美国规模领先的区域知名食品品牌，可生产四十余种意面产品，在当地市场拥有较高的认可度。
ASRT vs LRHC — 直观对比
营收规模更大
LRHC
是对方的1.5倍
$13.5M
营收增速更快
LRHC
高出61.1%
-57.9%
两年增速更快
LRHC
近两年复合增速
-35.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $20.2M |
| 净利润 | — | $-5.5M |
| 毛利率 | — | 8.4% |
| 营业利润率 | -86.7% | -24.7% |
| 净利率 | — | -27.4% |
| 营收同比 | -57.9% | 3.2% |
| 净利润同比 | — | -125.7% |
| 每股收益（稀释后） | $-4.54 | $-5.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTLRHC
| Q4 25 | $13.5M | — | ||
| Q3 25 | $49.5M | $20.2M | ||
| Q2 25 | $29.2M | $23.2M | ||
| Q1 25 | $26.5M | $17.5M | ||
| Q4 24 | $32.2M | $17.7M | ||
| Q3 24 | $29.2M | $19.6M | ||
| Q2 24 | $31.1M | $19.1M | ||
| Q1 24 | $32.4M | $13.1M |
净利润ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | $11.4M | $-5.5M | ||
| Q2 25 | $-16.4M | $78.4M | ||
| Q1 25 | $-13.5M | $-95.7M | ||
| Q4 24 | — | $-5.1M | ||
| Q3 24 | $-2.9M | $-2.5M | ||
| Q2 24 | $-3.7M | $-2.3M | ||
| Q1 24 | $-4.5M | $-4.6M |
毛利率ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | 8.8% | ||
| Q4 24 | — | 8.9% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 8.3% | ||
| Q1 24 | — | 8.9% |
营业利润率ASRTLRHC
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | -24.7% | ||
| Q2 25 | -27.5% | -10.6% | ||
| Q1 25 | -50.0% | -26.7% | ||
| Q4 24 | -41.9% | -17.1% | ||
| Q3 24 | -10.4% | -8.9% | ||
| Q2 24 | -11.6% | -9.7% | ||
| Q1 24 | -13.4% | -35.0% |
净利率ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | -27.4% | ||
| Q2 25 | -56.0% | 337.8% | ||
| Q1 25 | -51.1% | -546.5% | ||
| Q4 24 | — | -28.7% | ||
| Q3 24 | -10.0% | -12.5% | ||
| Q2 24 | -11.8% | -12.2% | ||
| Q1 24 | -13.9% | -35.1% |
每股收益（稀释后）ASRTLRHC
| Q4 25 | $-4.54 | — | ||
| Q3 25 | $0.11 | $-5.44 | ||
| Q2 25 | $-0.17 | $15.25 | ||
| Q1 25 | $-0.14 | $-5.86 | ||
| Q4 24 | $-3.28 | $28.54 | ||
| Q3 24 | $-0.03 | $-16.49 | ||
| Q2 24 | $-0.04 | $-12.49 | ||
| Q1 24 | $-0.05 | $-0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | $4.0M |
| 总债务越低越好 | — | $642.8K |
| 股东权益账面价值 | $94.0M | $1.6M |
| 总资产 | $267.0M | $21.7M |
| 负债/权益比越低杠杆越低 | — | 0.41× |
8季度趋势，按日历期对齐
现金及短期投资ASRTLRHC
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | $4.0M | ||
| Q2 25 | $98.2M | $5.1M | ||
| Q1 25 | $87.3M | $2.9M | ||
| Q4 24 | $100.1M | $1.4M | ||
| Q3 24 | $88.6M | $1.8M | ||
| Q2 24 | $88.4M | $1.6M | ||
| Q1 24 | $80.7M | $1.1M |
总债务ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | $642.8K | ||
| Q2 25 | — | $644.3K | ||
| Q1 25 | — | $645.9K | ||
| Q4 24 | — | $647.6K | ||
| Q3 24 | — | $649.2K | ||
| Q2 24 | — | $650.8K | ||
| Q1 24 | $38.6M | $652.4K |
股东权益ASRTLRHC
| Q4 25 | $94.0M | — | ||
| Q3 25 | $105.8M | $1.6M | ||
| Q2 25 | $93.3M | $3.4M | ||
| Q1 25 | $108.5M | $-87.5M | ||
| Q4 24 | $121.1M | $2.6M | ||
| Q3 24 | $130.5M | $5.0M | ||
| Q2 24 | $132.2M | $4.7M | ||
| Q1 24 | $134.5M | $5.6M |
总资产ASRTLRHC
| Q4 25 | $267.0M | — | ||
| Q3 25 | $319.8M | $21.7M | ||
| Q2 25 | $273.8M | $22.9M | ||
| Q1 25 | $286.4M | $21.0M | ||
| Q4 24 | $284.7M | $19.4M | ||
| Q3 24 | $276.0M | $19.7M | ||
| Q2 24 | $279.4M | $18.7M | ||
| Q1 24 | $282.0M | $16.3M |
负债/权益比ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | 0.41× | ||
| Q2 25 | — | 0.19× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | 0.29× | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $-1.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTLRHC
| Q4 25 | $-30.0M | — | ||
| Q3 25 | $-4.8M | $-1.3M | ||
| Q2 25 | $19.1M | $-1.4M | ||
| Q1 25 | $-12.5M | $-3.5M | ||
| Q4 24 | $11.5M | $-1.1M | ||
| Q3 24 | $-35.0K | $-591.6K | ||
| Q2 24 | $7.4M | $-803.1K | ||
| Q1 24 | $7.5M | $-538.3K |
资本支出强度ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ASRTLRHC
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
LRHC
| Real Estate Residential Brokerage Services | $16.8M | 83% |
| Transferred Over Time | $3.5M | 17% |
